Chronic Lymphocytic Leukemia | Clinical

Venugopal Considers BTK and BCL2 Inhibitors in Patient With CLL

July 22, 2021

Treatment for a patient with chronic lymphocytic leukemia who has comorbidities including hypertension and atrial fibrillation was the topic of discussion during a Targeted Oncology Case-Based Roundtable event led by Parameswaran Venugopal, MD.

Current and Future Challenges in the Treatment of CLL

July 16, 2021

Andrew Zelenetz, MD, reflects on the impact of moving agents to the frontline for treatment of chronic lymphocytic leukemia and how that impacts treatment decisions in relapsed/refractory chronic lymphocytic leukemia.